Fundai

Amin Pharmaceutical Company (DAMIN) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DAMIN
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/09/30To 1403/09/30To 1402/09/30To 1401/09/30To 1400/09/30
Cash generated from operations8,161,2908,246,8331,970,6543,187,847228,188442,733
Cash payments for income tax-183,473-209,262-499,521-163,116-133,650-103,395
Net cash inflow (outflow) from operating activities7,977,8178,037,5711,471,1333,024,73194,538339,338
Cash payments for purchase of property, plant and equipment-10,458,251-1,281,239-454,608-324,730-146,281-112,926
Cash receipts from sale of long-term investments52,75000000
Cash receipts from sale of short-term investments3,20000000
Cash payments for loans granted to others-600,81500---
Cash receipts from interest on other investments114,8408,3524,644674,37210,61015,195
Net cash inflow (outflow) from investing activities-10,888,276-1,227,930-487,464315,892-138,371-103,731
Net cash inflow (outflow) before financing activities-2,910,4596,809,641983,6693,340,623-43,833235,607
Cash receipts from facilities14,769,77416,529,63313,078,07510,513,6328,096,9945,110,326
Cash payments for principal of loans-13,008,234-16,246,494-13,000,978-10,681,528-6,905,169-4,554,668
Cash payments for interest on loans-2,477,886-2,129,168-1,775,954-1,182,863-746,807-442,345
Cash payments for dividends-208,7220-404,318-318,293-231,052-139,515
Net cash inflow (outflow) from financing activities-925,068-1,961,097-2,103,175-1,669,052213,966-26,202
Net increase (decrease) in cash-3,835,5274,848,544-1,119,5061,671,571170,133209,405
Cash balance at beginning of year5,206,875351,3261,962,917920,366385,592191,498
Effect of changes in exchange rates24,5977,00504,46301,531
Cash balance at end of year1,395,9455,206,875843,4112,596,400555,725402,434

Reporting periods

76 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.